A national survey evaluates public feelings about xenotransplantation, indicating mixed awareness and acceptance levels.
The Chinese public demonstrates a relatively high level of awareness and a moderately favorable acceptance of XTx. However, respondents exhibit incomplete knowledge of inherent residual risks, immune rejection, and long-term efficacy in XTx. At the same time, they hold overly optimistic expectations regarding its therapeutic outcomes and associated costs.
No takes yet. Share an insight, caveat, or question.
Kuang et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: